You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
調出港股通 東陽光藥(1558.HK)四連跌 股價創歷史新低
格隆匯 09-09 15:02
格隆匯9月9日丨東陽光藥(1558.HK)盤中一度跌超11%至4.21港元,連續第四日下跌,股價創歷史新低,市值37億港元。深交所9月6日發佈公吿顯示,東陽光藥被調出港股通標的。而在不久前的8月31日,東陽光方面稱,擬向廣東東陽光藥業有限公司及其控股子公司轉讓宜昌東陽光長江藥業股份有限公司不超過51.41%股權,以置出旗下醫藥板塊。東陽光的醫藥業務板塊,正在從東陽光集團剝離。新冠疫情的客觀環境和眾多競爭產品的湧入,使得東陽光藥的支柱產品奧司他韋營收遭遇斷崖式下跌。2021年上半年,東陽光藥營業額2.02億元,與上年同期相比下降90.3%,毛利率為1億元,與上年同期相比下降94.2%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account